These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10182116)

  • 1. Do different heparin brands influence activated clotting times?
    Dyck L; Friesen RM
    J Extra Corpor Technol; 1998 Jun; 30(2):73-6. PubMed ID: 10182116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in heparin potency and effects on the activated clotting time in children undergoing cardiopulmonary bypass.
    Guzzetta NA; Amin SJ; Tosone AK; Miller BE
    Anesth Analg; 2012 Oct; 115(4):921-4. PubMed ID: 22822188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass.
    Clark TD; Ecklund JM; McCall MM; Wolk DR; Riley JB
    J Extra Corpor Technol; 1996 Jun; 28(2):67-70. PubMed ID: 10160446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the new USP assay for heparin affected dosage for patients undergoing cardiopulmonary bypass?
    Anderson DA; Holt DW
    J Extra Corpor Technol; 2013 Jun; 45(2):112-5. PubMed ID: 23930380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin concentrations in neonates during cardiopulmonary bypass.
    Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
    J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
    [No Abstract]   [Full Text] [Related]  

  • 9. Extracorporeal heparin adsorption following cardiopulmonary bypass with a heparin removal device--an alternative to protamine.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Zwischenberger JB
    Crit Care Med; 1998 Jun; 26(6):1096-102. PubMed ID: 9635661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much heparin do we really need to go on pump? A rethink of current practices.
    Shuhaibar MN; Hargrove M; Millat MH; O'Donnell A; Aherne T
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):947-50. PubMed ID: 15519187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activated clotting time loading dose response ratio (ACTLORR) as an indicator of heparin demand during cardiopulmonary bypass.
    Reece IJ; Linley G; al Tareif H; DeVroege R; Tolia J; Sheth J
    Perfusion; 1996 Mar; 11(2):125-30. PubMed ID: 8740353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ; Alsoufiev AL; Spitznagel E; Goodnough LT; Lappas DG
    Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of New Heparin Potency on Activated Clotting Time during Pediatric Cardiac Surgery: A Retrospective Chart Review.
    Thompson K; Alred J; Deyo A; Sievert AN; Sistino JJ
    J Extra Corpor Technol; 2014 Sep; 46(3):224-8. PubMed ID: 26357788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald DJ; Patel A; Body SC; Garvin S
    Perfusion; 2009 Mar; 24(2):93-6. PubMed ID: 19654150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formal heparin anticoagulation protocol improves safety of charcoal-based liver-assist treatments.
    Hillebrand DJ; Hill KB; Hu KQ; Strutt M; Wilson B; Cottrell A; Teichman S; Hay K; Bull B
    ASAIO J; 2006; 52(3):334-42. PubMed ID: 16760725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory.
    Moffett BS; Teruya J; Petit C
    Ann Pharmacother; 2011 Jul; 45(7-8):876-80. PubMed ID: 21775696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.